Teladoc Health (NYSE:TDOC – Free Report) had its target price lowered by Evercore ISI from $14.00 to $10.00 in a research note published on Tuesday morning, Benzinga reports. The firm currently has an in-line rating on the health services provider’s stock.
TDOC has been the subject of a number of other research reports. Canaccord Genuity Group reduced their target price on Teladoc Health from $28.00 to $25.00 and set a buy rating for the company in a research note on Friday, April 26th. Stifel Nicolaus reduced their target price on Teladoc Health from $21.00 to $16.00 and set a hold rating for the company in a research note on Friday, April 26th. JPMorgan Chase & Co. reduced their target price on Teladoc Health from $19.00 to $16.00 and set a neutral rating for the company in a research note on Tuesday, May 21st. Royal Bank of Canada reduced their target price on Teladoc Health from $25.00 to $18.00 and set an outperform rating for the company in a research note on Friday, April 26th. Finally, Barclays cut their price target on Teladoc Health from $25.00 to $20.00 and set an overweight rating on the stock in a research report on Friday, April 26th. Thirteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of Hold and an average price target of $17.97.
View Our Latest Stock Report on Teladoc Health
Teladoc Health Trading Up 0.2 %
Teladoc Health (NYSE:TDOC – Get Free Report) last issued its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. During the same quarter in the prior year, the company posted ($0.37) EPS. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, research analysts expect that Teladoc Health will post -1.05 earnings per share for the current year.
Insider Buying and Selling
In related news, insider Laizer Kornwasser sold 10,411 shares of Teladoc Health stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the sale, the insider now directly owns 86,070 shares in the company, valued at approximately $1,092,228.30. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, insider Laizer Kornwasser sold 10,411 shares of Teladoc Health stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the sale, the insider now directly owns 86,070 shares in the company, valued at approximately $1,092,228.30. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Michael Willem Waters sold 5,793 shares of Teladoc Health stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the completion of the sale, the chief operating officer now owns 64,881 shares in the company, valued at $823,339.89. The disclosure for this sale can be found here. In the last three months, insiders have sold 32,592 shares of company stock worth $397,064. Insiders own 0.95% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. ICA Group Wealth Management LLC purchased a new position in Teladoc Health in the 4th quarter worth approximately $28,000. Hexagon Capital Partners LLC lifted its stake in Teladoc Health by 204.4% in the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after purchasing an additional 1,065 shares in the last quarter. RIA Advisory Group LLC purchased a new position in Teladoc Health in the 4th quarter worth approximately $36,000. GAMMA Investing LLC purchased a new position in Teladoc Health in the 4th quarter worth approximately $41,000. Finally, Principal Securities Inc. purchased a new position in Teladoc Health in the 4th quarter worth approximately $45,000. 76.82% of the stock is owned by hedge funds and other institutional investors.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories
- Five stocks we like better than Teladoc Health
- What Are Trending Stocks? Trending Stocks Explained
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- This Financial Stock’s Earnings Signal a Buying Opportunity
- Top Stocks Investing in 5G Technology
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.